Priceline delivers profit growth for Wesfarmers

Wesfarmers Health lifted profits in 2025, with Priceline sales and network growth partly driving the division’s results, the group told shareholders The decision to cut prices on key Priceline value lines has paid off for the Wesfarmers Health division, with the “strong sales growth” from the chain, the group’s chairman and managing director told investors.